Dr. Kim on the Multidisciplinary Management of HCC


Joseph Kim, MD, discusses the multidisciplinary management of hepatocellular carcinoma.

Joseph Kim, MD, professor of surgery and chief, Division of Surgical Oncology, University of Kentucky Markey Cancer Center, discusses the multidisciplinary management of hepatocellular carcinoma (HCC).

When patients with HCC present to Markey Cancer Center, their case is discussed at a multidisciplinary tumor board, Kim says. This is done in order for all health care professionals involved in the patient's treatment to present their expertise and formulate a treatment strategy.

It starts with the radiologist who interprets the imaging studies, followed by the pathologist who reviews the biopsy if one has been performed. Radiation oncologists, medical oncologists, and surgeons, which may include transplant surgeons and hepatobiliary surgeons, are involved in the optimal management of this disease, making treatment multidisciplinary in nature, Kim concludes.

Related Videos
Pamela L. Kunz, MD, associate professor, internal medicine (medical oncology), Yale School of Medicine; director, Center for Gastrointestinal (GI) Cancers, chief, GI Medical Oncology, Smilow Cancer Hospital, Yale Cancer Center
Suneel Kamath, MD
Suneel Kamath, MD
Jennifer R. Eads, MD, physician lead, GI Cancer Research, director, National Clinical Trials Network, Abramson Cancer Center, University of Pennsylvania, associate professor, clinical medicine (hematology-oncology), Penn Medicine, Perelman Center for Advanced Medicine
Olivia Aranha, MD, PhD
Michael Iglesia, MD, PhD
Petros Grivas, MD, PhD; and Chandler Park, MD, MSc, FACP
Arndt Vogel, MD
Daniel M. Halperin, MD, associate professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Haeseong Park, MD, MPH